Modulation of Vasoconstriction by Clopidogrel and Ticlopidine - A new safe and effective antiplatelet agent. But unanswered questions remain

Author： Yang L.H.   Hoppensteadt D.   Fareed J.  

Publisher： Elsevier

ISSN： 0049-3848

Source： Thrombosis Research, Vol.92, Iss.2, 1998-10, pp. : 83-89

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

VASOMODULATORY ACTION OF CLOPIDOGREL AND TICLOPIDINE

By Yang L.H.   Fareed J.  

Thrombosis Research, Vol. 86, Iss. 6, 1997-06 ,pp. : 479-491

Elsevier

Access to resources Recommend Favorite

Failure to monitor ticlopidine: the case for clopidogrel

By Richardson Gail   Curzen Nicholas P   Preston Melanie A   Mills Peter G   Timmis Adam D   Rothman Martin T  

International Journal of Cardiovascular Interventions, Vol. 3, Iss. 1, 2000-03 ,pp. : 29-33

Informa Healthcare

Access to resources Recommend Favorite

Synthetic isoxazole as antiplatelet agent

By Gutiérrez Margarita   Amigo Jessica   Fuentes Eduardo   Palomo Ivan   Astudillo Luis  

Platelets, Vol. 25, Iss. 4, 2014-06 ,pp. : 234-238

Informa Healthcare

Access to resources Recommend Favorite

Clinical Trials: Evidence and Unanswered Questions – Hyperlipidaemia

By  

Cerebrovascular Diseases, Vol. 16, Iss. 3, 2003-06 ,pp. : 25-32

Karger

Access to resources Recommend Favorite

Clinical Trials: Evidence and Unanswered Questions – Hypertension

By  

Cerebrovascular Diseases, Vol. 16, Iss. 3, 2003-06 ,pp. : 18-24

Karger

Access to resources Recommend Favorite